Tabrizi A, Mohseni Ashjerdi M, Ghazizadeh M, Maleki M
Iran J Otorhinolaryngol. 2023; 35(130):263-273.
PMID: 38090619
PMC: 10712552.
DOI: 10.22038/IJORL.2023.71462.3429.
Sanei-Taheri M, Mahboubi-Fooladi Z, Soleimani R
Curr J Neurol. 2023; 20(1):49-51.
PMID: 38011436
PMC: 8511604.
DOI: 10.18502/cjn.v20i1.6380.
Liu Z, Vaira L, Boscolo-Rizzo P, Walker A, Hopkins C
BMJ Med. 2023; 2(1):e000382.
PMID: 37841969
PMC: 10568123.
DOI: 10.1136/bmjmed-2022-000382.
Doty R
Trends Mol Med. 2022; 28(9):781-794.
PMID: 35810128
PMC: 9212891.
DOI: 10.1016/j.molmed.2022.06.005.
Vaira L, Deiana G, Lechien J, De Vito A, Cossu A, Dettori M
Laryngoscope. 2021; 131(10):2312-2318.
PMID: 34287905
PMC: 8441733.
DOI: 10.1002/lary.29777.
Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
Las Casas Lima M, Cavalcante A, Leao S
Braz J Otorhinolaryngol. 2021; 88(5):794-802.
PMID: 33965353
PMC: 8068782.
DOI: 10.1016/j.bjorl.2021.04.001.
Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study.
Cousyn L, Sellem B, Palich R, Bendetowicz D, Agher R, Delorme C
Infect Dis Now. 2021; 51(5):440-444.
PMID: 33766735
PMC: 7983360.
DOI: 10.1016/j.idnow.2021.03.004.
Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients.
Vaira L, Lechien J, Khalife M, Petrocelli M, Hans S, Distinguin L
Pathogens. 2021; 10(1).
PMID: 33445604
PMC: 7827350.
DOI: 10.3390/pathogens10010062.
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
Le Bon S, Konopnicki D, Pisarski N, Prunier L, Lechien J, Horoi M
Eur Arch Otorhinolaryngol. 2021; 278(8):3113-3117.
PMID: 33423106
PMC: 7796691.
DOI: 10.1007/s00405-020-06520-8.
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.
Vaira L, Hopkins C, Sandison A, Manca A, Machouchas N, Turilli D
J Laryngol Otol. 2020; 134(12):1123-1127.
PMID: 33190655
PMC: 7729153.
DOI: 10.1017/S0022215120002455.
Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia.
Kandemirli S, Altundag A, Yildirim D, Sanli D, Saatci O
Acad Radiol. 2020; 28(1):28-35.
PMID: 33132007
PMC: 7571972.
DOI: 10.1016/j.acra.2020.10.006.
COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review.
Suri J, Puvvula A, Biswas M, Majhail M, Saba L, Faa G
Comput Biol Med. 2020; 124:103960.
PMID: 32919186
PMC: 7426723.
DOI: 10.1016/j.compbiomed.2020.103960.
Reply to "MRI Evaluation of the Olfactory Clefts in Patients with SARS-CoV-2 Infection Revealed an Unexpected Mechanism for Olfactory Function Loss".
Haseli S, Karimi-Galougahi M
Acad Radiol. 2020; 27(8):1192.
PMID: 32553280
PMC: 7284249.
DOI: 10.1016/j.acra.2020.05.025.
Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population.
Iravani B, Arshamian A, Ravia A, Mishor E, Snitz K, Shushan S
Chem Senses. 2020; .
PMID: 32441744
PMC: 7314115.
DOI: 10.1093/chemse/bjaa034.
